Page 327 - IJB-10-4
P. 327

International

                                                                         Journal of Bioprinting



                                        RESEARCH ARTICLE
                                        3D bioprinting of betamethasone-loaded gellan

                                        gum–polyethyleneimine composite hydrogels
                                        for ocular drug delivery



                                        Negin Khoshnood 1 id , John P. Frampton * , Armin Badri , and Ali Zamanian *
                                                                                        1
                                                                                                         1 id
                                                                         2 id
                                        1 Department of Nanotechnology and Advanced Materials, Materials and Energy Research Center
                                        (MERC), Karaj, Alborz, Iran
                                        2 Department of Biochemistry and Molecular Biology, School of Biomedical Engineering, Dalhousie
                                        University, Halifax, Nova Scotia, Canada
                                        (This article belongs to the Special Issue: Bioprinting for Tissue Engineering and Modeling)

                                        Abstract

                                        Transparent hydrogels have numerous applications in materials science and tissue
                                        engineering, particularly as materials for corneal repair. In this study, we developed
                                        a three-dimensional (3D)-bioprinted betamethasone sodium phosphate-loaded
                                        gellan gum (GG)–polyethyleneimine (PEI) composite hydrogel and assessed its
                                        performance in vitro. The bioinks used for 3D bioprinting were optimized based on
                                        their transparency and gelation properties. In the presence of an ionic crosslinker
                                        (citric acid), the GG–PEI blend transformed from a liquid precursor to an extrudable
            *Corresponding authors:     hydrogel with good printability and shape fidelity. The 2.5% GG–3% PEI hydrogel
            Ali Zamanian                formulation had a transparency of 80%, a suitable degradation rate, and sufficient
            (a-zamanian@merc.ac.ir)     mechanical strength for application in corneal repair. The GG–PEI composite hydrogel
            John P. Frampton            displayed controlled and sustained release of betamethasone sodium phosphate.
            (john.frampton@dal.ca)
                                        Moreover, the 3D-bioprinted composite hydrogel was biocompatible, as evidenced

            Citation: Khoshnood N,      by the attachment, growth, and proliferation of corneal fibroblasts. Taken together,
            Frampton JP, BadriA,        these findings suggest that the 3D-bioprinted GG–PEI composite hydrogel scaffold


            ZamanianA. 3D bioprinting of

            betamethasone-loaded gellan   has the potential to control ocular inflammation and aid in corneal tissue healing.
            gum-polyethyleneimine composite
            hydrogels for ocular drug delivery.
            Int J Bioprint. 2024;10(4):3440.     Keywords: Gellan gum hydrogel; Polyethyleneimine; Bioink; 3D-bioprinted scaffold;
            doi: 10.36922/ijb.3440      Ocular drug delivery; Corneal tissue engineering
            Received: April 17, 2024
            Accepted: June 6, 2024
            Published Online: July 16, 2024
            Copyright: © 2024 Author(s).   1. Introduction
            This is an Open Access article
            distributed under the terms of the   The cornea is a transparent multilayer structure in the eye that focuses light. Advancements
            Creative Commons Attribution   in surgical technology have enabled selective transplantation of specific corneal layers,
            License, permitting distribution,                                          1,2
            and reproduction in any medium,   particularly in cases limited to damage of the anterior cornea.  However, limited supplies
            provided the original work is   of high-quality donor corneas and donor tissue rejection remain concerns. To address
            properly cited.             some of the limitations associated with the transplantation of donor corneal tissue, the
            Publisher’s Note: AccScience   replacement of diseased or damaged corneal tissue with functional biomaterials has
            Publishing remains neutral with   attracted considerable attention in recent years.  The development of materials for
                                                                               3,4
            regard to jurisdictional claims in
            published maps and institutional   corneal repair and replacement has been a focused research area encompassing ocular
            affiliations.               science, biomaterials, and advanced manufacturing. 5,6




            Volume 10 Issue 4 (2024)                       319                                doi: 10.36922/ijb.3440
   322   323   324   325   326   327   328   329   330   331   332